SS-A/Ro52 promotes apoptosis by regulating Bcl-2 production

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 582-587

  Jauharoh, Siti Nur Aisyah ^a,c   Saegusa, Jun ^a   Sugimoto, Takeshi ^a   Ardianto, Bambang ^a,d   Kasagi, Shimpei ^a   Sugiyama, Daisuke ^a   Kurimoto, Chiyo ^a   Tokuno, Osamu ^b   Nakamachi, Yuji ^b   Kumagai, Shunichi ^a   Kawano, Seiji ^a,b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY HOSPITAL   (Japan)

^c SYARIF HIDAYATULLAH STATE ISLAMIC UNIVERSITY   (Indonesia)

^d GADJAH MADA UNIVERSITY   (Indonesia)

Author keywords

Apoptosis; Bcl 2; P53; SS A Ro52; TRIM21

Indexed keywords

ALPHA INTERFERON; ETOPOSIDE; FAS ANTIBODY; GAMMA INTERFERON; PROTEIN BCL 2; PROTEIN P53; RIBONUCLEOPROTEIN; RO52 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GAMMA IRRADIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; CELL NUCLEUS; DIAMIDE; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; INTERFERON-ALPHA; INTERFERON-GAMMA; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RIBONUCLEOPROTEINS;

EID: 84855790335     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.010     Document Type: Article

References (26)

1. Frank M.B., Itoh K., McCubbin V. Epitope mapping of the 52-kD Ro/SSA autoantigen. Clinical and Experimental Immunology 1994, 95:390-396.
2. Bozic B., Pruijn G.J., Rozman B., van Venrooij W.J. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein. Clinical and Experimental Immunology 1993, 94:227-235.
3. Buyon J.P., Slade S.G., Reveille J.D., Hamel J.C., Chan E.K. Autoantibody responses to the " native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus and Sjógren's syndrome. Journal of Immunology 1994, 152:3675-3684.
4. Casciola-Rosen L.A., Anhalt G., Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. Journal of Experimental Medicine 1994, 179:1317-1330.
5. Saegusa J., Kawano S., Koshiba M., Hayashi N., Kosaka H., Funasaka Y., Kumagai S. Oxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytes. Free Radical Biology and Medicine 2002, 32:1006-1016.
6. Nobuhara Y., Kawano S., Kageyama G., Sugiyama D., Saegusa J., Kumagai S. Is SS-A/Ro52 a hydrogen peroxide-sensitive signaling molecule?. Antioxidants Redox Signaling 2007, 9:385-391.
7. Hennig J., Ottosson L., Andrésen C., Horvath L., Kuchroo V.K., Broo K., Wahren-Herlenius M., Sunnerhagen M. Structural organization and Zn2+-dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52. Journal of Biological Chemistry 2005, 280:33250-33261.
8. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. The tripartite motif family identifies cell compartments. EMBO Journal 2001, 20:2140-2151.
9. Torok M., Etkin L.D. Two B or not two B? Overview of the rapidly expanding B-box family of proteins. Differentiation 2001, 67:63-71.
10. Takahata M., Bohgaki M., Tsukiyama T., Kondo T., Asaka M., Hatakeyama S. Ro52 functionally interacts with IgG1 and regulates its quality control via the ERAD system. Molecular Immunology 2008, 45:2045-2054.
11. Yang Y.S., Yang M.C., Wang B., Weissler J.C. Autoantigen Ro52 directly interacts with human IgG heavy chain in vivo in mammalian cells. Molecular Immunology 2000, 37:591-602.
12. Mallery D.L., McEwan W.A., Bidgood S.R., Towers G.J., Johnson C.M., James L.C. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proceedings of the National Academy of Sciences of the United States of America 2010, 107:19985-19990.
13. Higgs R., Ní Gabhann J., Larbi N.B., Breen E.P., Fitzgerald K.A., Jefferies C.A. The E3 ubiquitin ligase Ro52 negatively regulates IFN-β production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3. Journal of Immunology 2008, 181:1780-1786.
14. Higgs R., Lazzari E., Wynne C., Ní Gabhann J., Espinosa A., Wahren-Herlenius M., Jefferies C.A. Self protection from anti-viral responses - Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-like receptors. PLoS One 2010, 5:e11776.
15. Kong H.J., Anderson D.E., Lee C.H., Jang M.K., Tamura T., Tailor P., Cho H.K., Cheong J., Xiong H., Morse H.C., Ozato K. Autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. Journal of Immunology 2007, 179:26-30.
16. Yoshimi R., Chang T.H., Wang H., Atsumi, Morse H.C., Ozato K. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. Journal of Immunology 2009, 182:7527-7538.
17. Wada K., Niida M., Tanaka M., Kamitani T. Ro52-mediated monoubiquitination of IKK{beta} down-regulates NF-{kappa}B signaling. Journal of Biochemistry 2009, 146:821-832.
18. Espinosa A., Dardalhon V., Brauner S., Ambrosi A., Higgs R., Quintana F.J., Sjöstrand M., Eloranta M.L., Ní Gabhann J., Winqvist O., Sundelin B., Jefferies C.A., Rozell B., Kuchroo V.K., Wahren-Herlenius M. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. Journal of Experimental Medicine 2009, 206:1661-1671.
19. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993, 74:957-967.
20. Strandberg L., Ambrosi A., Espinosa A., Ottosson L., Eloranta M.L., Zhou W., Elfving A., Greenfield E., Kuchroo V.K., Wahren-Herlenius M. Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies. Journal of Clinical and Experimental Immunology 2008, 28:220-231.
21. Espinosa A., Zhou W., Ek M., Hedlund M., Brauner S., Popovic K., Horvath L., Wallerskog T., Oukka M., Nyberg F., Kuchroo V.K., Wahren-Herlenius M. Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. Journal of Immunology 2006, 176:6277-6285.
22. Alarcon-Segovia D., Ruiz-Arguelles A., Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 1978, 271:67-69.
23. Lisi S., Sisto M., Lofrumento D., Frassanito M.A., Caprio S., Romano M.L., Mitolo V., D'Amore M. Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies. Clinical and Experimental Medicine 2010, 10:199-203.
24. Yanase K., Smith R.M., Puccetti A., Jarett L., Madaio M.P. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. Journal of Clinical Investigation 1997, 100:25-31.
25. Mallery D.L., McEwana W.A., Bidgooda S.R., Towersb G.J., Johnsona C.M., Jamesa L.C. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proceedings of the National Academy of Sciences of the United States of America 2010, 107:19985-19990.
26. Espinosa A., Hennig J., Ambrosi A., Anandapadmanaban M., Abelius M.S., Sheng Y., Nyberg F., Arrowsmith C.H., Sunnerhagen M., Wahren-Herlenius M. Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface. Journal of Biological Chemistry 2011, 286:36478-36491.